학술논문
Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150.
Document Type
Article
Author
Source
Tumor Biology (IOS Press); 2024 Supplement, Vol. 46, pS177-S190, 14p
Subject
Language
ISSN
10104283
Abstract
Copyright of Tumor Biology (IOS Press) is the property of IOS Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)